Is Zymeworks, Inc. ZYME stock halal to invest in?

No, as of February 2026, Zymeworks, Inc. stock (ZYME) is currently categorized as NOT Shariah Compliant. The company's status is determined by a rigorous financial screening process, which uses the criteria set by the AAOIFI (Accounting and Auditing Organization for Islamic Financial Institutions) as the primary global standard for Islamic investing. Zymeworks, Inc. has been assessed to have exceeded the permissible financial thresholds—specifically in areas like interest-bearing debt or non-permissible income (such as income from interest)—and, therefore, does not qualify as a halal investment under the current review. For investors seeking Shariah compliant global stocks, it is essential to check the latest compliance status, as these screenings are updated regularly (e.g., monthly) or upon the release of new financial reports. You can find the most current status for Zymeworks, Inc. and alternative halal stock options within the Tabadulat app.

How often is Zymeworks, Inc. ZYME reviewed for Shariah compliance?

At Tabadulat, we receive Shariah compliance data on Zymeworks, Inc. ZYME monthly. We apply the rigorous AAOIFI screening methodology under the direct supervision of our dedicated Shariah Supervisory Board to ensure your investments are consistently compliant.

Does Zymeworks, Inc. ZYME pass the AAOIFI Non Permissible Income criteria?

No, as of February 2026, Zymeworks, Inc. stock (ZYME) does not pass the AAOIFI Non Permissible Income criterion. The company's income from non-permissible sources has exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

Does Zymeworks, Inc. ZYME pass the AAOIFI Interest Bearing Investments criteria?

Yes, as of February 2026, Zymeworks, Inc. stock (ZYME) passes the AAOIFI Interest Bearing Investments criterion. The company's interest-bearing investments are below the acceptable threshold set by AAOIFI.

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

Yes, as of February 2026, Zymeworks, Inc. stock (ZYME) passes the AAOIFI Interest Bearing Debt criterion. The company's interest-bearing debt is below the acceptable threshold set by AAOIFI.

English

العربية

Be the First to Know!

Join our waitlist for exclusive early access to Tabadulat’s Shariah-compliant trading platform. Get notified as soon as we go live and start investing with confidence.

Zymeworks, Inc.

NASDAQ

Shariah-Compliant

Not Shariah

ZYME

About

Zymeworks, Inc.

ZYME

Zymeworks Inc. is a biotechnology company that focuses on innovating biotherapeutics for the treatment of cancer and autoimmune diseases. The company's core mission revolves around developing novel, multifunctional therapeutics with the potential to improve efficacy and reduce side effects compared to conventional cancer treatments. Zymeworks utilizes its proprietary platforms, such as the Azymetric and EFECT technologies, which enable the creation of multifunctional antibody therapeutics. These assets are significant in sectors such as oncology and immunology, addressing unmet needs with therapies aimed at complex and difficult-to-treat conditions. Based in Canada, Zymeworks collaborates with leading global pharmaceutical companies to enhance the reach and impact of its research. In the financial market, Zymeworks Inc. is notable for its strategic partnerships and potential for contributing to advancements in precision medicine, emphasizing its role not only in scientific innovation but also as a key player in the biotech industry's approach to personalized healthcare solutions.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

273

Website:

https://www.zymeworks.com

ZYME

Frequently asked questions

Related stocks

Mobile login screen for Tabadulat with fields to enter email, a Continue button, an option to create an account, and a language selector showing EN.

Step 1

Sign Up.

Begin by creating your Tabadulat account. Simply enter your details and complete the verification process. You’ll be up and running in no time.

Mobile screen showing add money interface with 100 AED amount and Manual Bank Transfer payment method selected, noting 1-2 business days processing.

Step 2

Deposit.

Add funds to your account using a secure payment method. You can deposit in multiple currencies to get started.

Step 3

Screen.

Screen Stocks for Free and explore a wide range of stocks that are ethically screened for Shariah compliance. Use our Halal Stock Screener to find the best opportunities.

Step 4

Trade.

Once you’ve chosen the right stocks, simply place your trades. Our platform offers real-time market data and seamless execution.

Mobile screen showing investment portfolio with $100,000 total value, $48,000 invested, and a $2,000 return (4.50%) with a line graph and options for 1W, 1M, 3M, YTD, 1Y, Max, plus Trade and Deposit buttons.

Step 5

Track.

Track your Portfolio and monitor your investments with our easy-to-use dashboard. View your portfolio performance, manage assets, and make adjustments as needed.

Step 6

Withdraw.

When you're ready, withdraw your funds quickly and securely to your bank account.

Zymeworks, Inc.

About

Zymeworks, Inc.

ZYME

Frequently asked questions

Is Zymeworks, Inc. ZYME stock halal to invest in?

How often is Zymeworks, Inc. ZYME reviewed for Shariah compliance?

Does Zymeworks, Inc. ZYME pass the AAOIFI Non Permissible Income criteria?

Does Zymeworks, Inc. ZYME pass the AAOIFI Interest Bearing Investments criteria?

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

How do I buy Zymeworks, Inc. ZYME stock?

Sign Up.

Deposit.

Screen.

Trade.

Track.

Withdraw.